<!DOCTYPE HTML>
<!--
	Hielo by TEMPLATED
	templated.co @templatedco
	Released for free under the Creative Commons Attribution 3.0 license (templated.co/license)
-->
<html>
	<head>
		<title>Resources</title>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1" />
		<link rel="stylesheet" href="assets/css/main.css" />
	</head>
	<body class="subpage">

		<!-- Header -->
			<header id="header">
				<div class="logo"><a href="index.html">Kroncke Laboratory</a></div>
				<a href="#menu">Menu</a>
			</header>

			<!-- Nav -->
				<nav id="menu">
					<ul class="links">
						<li><a href="index.html">Home</a></li>
						<li><a href="ResearchProjects.html">Research Projects</a></li>
						<li><a href="People.html">People</a></li>
						<li><a href="https://www.ncbi.nlm.nih.gov/pubmed?term=Kroncke+B*">Publications</a></li>
						<li><a href="Resources.html">Resources</a></li>
						<li><a href="OpenPositions.html">Open Positions</a></li>
					</ul>
				</nav>

		<!-- One -->
			<section id="One" class="wrapper style3">
				<div class="inner">
					<header class="align-center">
						<p>What can help you determine the significance of genetic variants?</p>
						<h2>Resources</h2>
					</header>
				</div>
			</section>

		<!-- Two -->
			<section id="two" class="wrapper style2">
				<div class="inner">
					<div class="box">
						<div class="content">
							<header class="align-center">
								<h2>What is the significance of genetic variants to those that carry them?</h2>
							</header>
							<p>The increasing use of next generation sequencing in the clinical arena is uncovering a large number of variants across all genes, but methods to predict their pathogenicity are not well established. This results in an increasing number of “variants of uncertain significance” (VUSs), a major emerging problem in genomic medicine. Rare variants (mutations) in the cardiac ion channels are implicated in diverse heart diseases, including, long QT syndrome (LQTS), short QT syndrome (SQTS), and Brugada syndrome (BrS), but are also common in healthy populations. While multiple algorithms predict whether ion channel variants are deleterious (SIFT, PolyPhen-2, PredSNP, CADD, etc.), too many neutral variants are classified as disease-causing. The long-term research interest of the laboratory is to improve our understanding of the clinical burden of ion channel non-synonymous single nucleotide polymorphisms (nsSNPs) on carriers. I believe predicting protein-specific functional phenotypes accurately of nsSNPs within these genes is the best path to reaching this goal. Our initial efforts will focus on the ion channels associated with LQT1, LQT2, LQT3, and LQT5.</p>
            </div>
					</div>
				</div>
			</section>

		<!-- Footer -->
			<footer id="footer">
				<div class="container">
					<ul class="icons">
						<li><a href="People.html" class="icon fa-envelope-o"><span class="label">Email</span></a></li>
					</ul>
				</div>
				Kroncke Laboratory<br>Vanderbilt University Medical Center<br>
			Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART)<br>1225E MRBIV<br>Nashville, TN 37232<br>Email: brett.kroncke@gmail.com
			</footer>

		<!-- Scripts -->
			<script src="assets/js/jquery.min.js"></script>
			<script src="assets/js/jquery.scrollex.min.js"></script>
			<script src="assets/js/skel.min.js"></script>
			<script src="assets/js/util.js"></script>
			<script src="assets/js/main.js"></script>

	</body>
</html>
